Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ezim Ajufo"'
Autor:
David Chang, Usha B. Tedrow, Thomas M. Tadros, Sunil Kapur, Nathaniel Steiger, Jorge Romero, David T. Martin, Bruce A. Koplan, Gary Peng, Ezim Ajufo, Carolina Hoyos-Ochoa, Estefania Rivera, Carlos Patino, Carlos Matos, Paul C. Zei, Anju Nohria, William H. Sauer
Publikováno v:
Heart Rhythm. 20:S98
Autor:
Marina Cuchel, Ezim Ajufo
Publikováno v:
Expert Opinion on Orphan Drugs. 5:933-943
Introduction: Familial hypercholesterolemia (FH) is a genetically heterogeneous disorder of low density lipoprotein metabolism characterized by lifelong elevation of serum low density lipoprotein cholesterol and premature valvular and atherosclerotic
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 12
Background: Many guidelines suggest a target LDL-C of Objective: To determine the cardiovascular disease burden and treatment patterns among patients with the ICD-10 code for FH at a tertiary academic center. Methods: A retrospective query was conduc
Autor:
Daniel J. Rader, Ezim Ajufo
Publikováno v:
Annual review of medicine. 69
Familial hypercholesterolemia (FH) is a common genetic condition characterized by elevated plasma levels of low-density lipoprotein cholesterol (LDL-C), premature atherosclerotic cardiovascular disease, and considerable unmet medical need with conven
Autor:
Ezim Ajufo, Masako Ueda, Tracey Sikora, Emil M deGoma, Kristen Dilzell, Anna Raper, Stephanie DerOhannessian, Erik Hossain, Megan L Mucksavage, Marina Cuchel, Daniel J Rader
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37
Background: Familial hypercholesterolemia (FH) is a common heritable disorder of elevated low density lipoprotein cholesterol (LDL-C) with an estimated prevalence of 1/200-300 in the US; however, fewer than 10% of cases have been identified. We wante
Autor:
Ezim Ajufo, Masako Ueda, Erik Hossain, Tracey Sikora, Scott M Damrauer, Emil M deGoma, Kristen Dilzell, Stephanie DerOhannessian, Marina Cuchel, Daniel J Rader
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37
Background: National and International guidelines recommend, as a minimum, that individuals with LDL-C ≥190mg/dL are asked about a family history of ASCVD and hypercholesterolemia to screen for familial hypercholesterolemia (FH), a monogenic condit
Autor:
Marina Cuchel, Ezim Ajufo
Publikováno v:
European heart journal. 38(8)
This editorial refers to ‘Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia’, by J. Bes
Autor:
Daniel J. Rader, Ezim Ajufo
Publikováno v:
The lancet. Diabetesendocrinology. 4(5)
Summary The recent developments in pharmacological interventions that reduce LDL cholesterol have been remarkable, coming more than a decade after the approval of the last LDL-cholesterol-lowering drug, the cholesterol absorption inhibitor ezetimibe.
Autor:
Tracey Sikora, Erik Hossain, Daniel J. Rader, Marina Cuchel, Emil M. deGoma, Kristen Dilzell, Ezim Ajufo, Stephanie DerOhannessian, Masako Ueda, Scott M. Damrauer
Publikováno v:
Journal of Clinical Lipidology. 11:800-801
Autor:
Tracey Sikora, Emil M. deGoma, Anna Raper, Marina Cuchel, Masako Ueda, Stephanie DerOhannessian, Ezim Ajufo, Daniel J. Rader, Kristen Dilzell
Publikováno v:
Journal of Clinical Lipidology. 11:790-791